Brind.

Warren Buffett discussed rational business valuation while Amgen's TSR exceeded its share price return.

1 report, 1 independent Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Warren Buffett discussed rational business valuation while Amgen's TSR exceeded its share price return.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Amgen

    American multinational biopharmaceutical company

    Nothing else this week.

  • Warren Buffett

    American investor, entrepreneur and businessman

    Nothing else this week.

  • TSR

    former company, publisher of Dungeons & Dragons

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns Buying a low-cost index fund will get you the average market return. But across the board there are plenty of s